ESEF — Europäische Jahresabschlüsse (iXBRL) fact · point in time
Hyloris Pharmaceuticals: cash_and_equivalents
One fact, its scope and the complete path back to the official record.
Reported value
30.406M{"amount": 30406000.0, "concept": "ifrs-full:CashAndCashEquivalents"}- Entity
- Hyloris Pharmaceuticals
- Metric
- cash_and_equivalents
- Period
- as of 2023-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:875500LZIWS7QEQE0I73:2025-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T22:32:27.872878+02:00
Raw response SHA-256
ebe25423f991af4ffc7920e4177f0fda…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.